Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    bioAffinity Technologies ...

    NASDAQ: BIAF · Real-Time Price · USD
    0.29
    0.01 (2.04%)
    At close: Jun 09, 2025, 3:59 PM

    bioAffinity Statistics

    Share Statistics

    bioAffinity has 28.46M shares outstanding. The number of shares has increased by 33.69% in one year.

    Shares Outstanding

    n/a
    		 28.46M

    Shares Change (YoY)

    n/a
    		 33.69%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 4.32%

    Shares Floating

    n/a
    		 20.25M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,871

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 459.51K, so 1.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 459.51K

    Short % of Shares Out

    n/a
    		 1.69%

    Short % of Float

    n/a
    		 1.83%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.22 and the forward PE ratio is -1.58. bioAffinity's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -1.22

    Forward PE

    n/a
    		 -1.58

    PS Ratio

    n/a
    		 1.18

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 4.24

    P/FCF Ratio

    n/a
    		 -1.5

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for bioAffinity.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.58.

    Current Ratio

    n/a
    		 0.87

    Quick Ratio

    n/a
    		 0.86

    Debt / Equity

    n/a
    		 0.58

    Debt / EBITDA

    n/a
    		 -0.18

    Debt / FCF

    n/a
    		 -0.2

    Interest Coverage

    n/a
    		 -96.82

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $164,246

    Profits Per Employee

    n/a
    		 $-158,593.53

    Employee Count

    n/a
    		 57

    Asset Turnover

    n/a
    		 1.44

    Inventory Turnover

    n/a
    		 216.73

    Taxes

    Income Tax

    n/a
    		 11.65K

    Effective Tax Rate

    n/a
    		 -0.13%

    Stock Price Statistics

    The stock price has increased by -87.83% in the last 52 weeks. The beta is 2.56, so bioAffinity's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.56

    52-Week Price Change

    n/a
    		 -87.83%

    50-Day Moving Average

    n/a
    		 0.41

    200-Day Moving Average

    n/a
    		 0.96

    Relative Strength Index (RSI)

    n/a
    		 46.47

    Average Volume (20 Days)

    n/a
    		 12,387,958

    Income Statement

    In the last 12 months, bioAffinity had revenue of 9.36M and earned -9.04M in profits. Earnings per share was -0.73.

    Revenue

    n/a
    		 9.36M

    Gross Profit

    n/a
    		 3.38M

    Operating Income

    n/a
    		 -8.95M

    Net Income

    n/a
    		 -9.04M

    EBITDA

    n/a
    		 -8.33M

    EBIT

    n/a
    		 -8.94M

    Earnings Per Share (EPS)

    n/a
    		 -0.73
    Full Income Statement

    Balance Sheet

    The company has 1.11M in cash and 1.5M in debt, giving a net cash position of -395.9K.

    Cash & Cash Equivalents

    n/a
    		 1.11M

    Total Debt

    n/a
    		 1.5M

    Net Cash

    n/a
    		 -395.9K

    Retained Earnings

    n/a
    		 -53.64M

    Total Assets

    n/a
    		 5.55M

    Working Capital

    n/a
    		 -1.55M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.26M and capital expenditures -79.08K, giving a free cash flow of -7.34M.

    Operating Cash Flow

    n/a
    		 -7.26M

    Capital Expenditures

    n/a
    		 -79.08K

    Free Cash Flow

    n/a
    		 -7.34M

    FCF Per Share

    n/a
    		 -0.61
    Full Cash Flow Statement

    Margins

    Gross margin is 36.09%, with operating and profit margins of -95.64% and -96.56%.

    Gross Margin

    n/a
    		 36.09%

    Operating Margin

    n/a
    		 -95.64%

    Pretax Margin

    n/a
    		 -96.43%

    Profit Margin

    n/a
    		 -96.56%

    EBITDA Margin

    n/a
    		 -88.98%

    EBIT Margin

    n/a
    		 -95.64%

    FCF Margin

    n/a
    		 -78.44%

    Dividends & Yields

    BIAF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BIAF is $6, which is 2042.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 2042.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -17.1

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist